These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 18388903)

  • 1. Obesity-related changes in high-density lipoprotein metabolism.
    Mooradian AD; Haas MJ; Wehmeier KR; Wong NC
    Obesity (Silver Spring); 2008 Jun; 16(6):1152-60. PubMed ID: 18388903
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of obesity on high-density lipoprotein metabolism.
    Rashid S; Genest J
    Obesity (Silver Spring); 2007 Dec; 15(12):2875-88. PubMed ID: 18198293
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of obesity in primary hyperlipidemias.
    Carmena R; Ascaso JF; Real JT
    Nutr Metab Cardiovasc Dis; 2001 Oct; 11(5):354-9. PubMed ID: 11887432
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High-density lipoprotein metabolism in familial hypercholesterolaemia: significance, mechanisms, therapy.
    Watts GF; Barrett PH
    Nutr Metab Cardiovasc Dis; 2002 Feb; 12(1):36-41. PubMed ID: 12125229
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Postprandial hyperlipidemia, small and dense LDL, HDL sub-fractions].
    Braschi S
    Ann Med Interne (Paris); 2001 Apr; 152(3):162-8. PubMed ID: 11431575
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhanced cellular uptake of remnant high-density lipoprotein particles: a mechanism for high-density lipoprotein lowering in insulin resistance and hypertriglyceridemia.
    Xiao C; Watanabe T; Zhang Y; Trigatti B; Szeto L; Connelly PW; Marcovina S; Vaisar T; Heinecke JW; Lewis GF
    Circ Res; 2008 Jul; 103(2):159-66. PubMed ID: 18556574
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relation of clinical benefit of raising high-density lipoprotein cholesterol to serum levels of low-density lipoprotein cholesterol in patients with coronary heart disease (from the Bezafibrate Infarction Prevention Trial).
    Goldenberg I; Benderly M; Sidi R; Boyko V; Tenenbaum A; Tanne D; Behar S
    Am J Cardiol; 2009 Jan; 103(1):41-5. PubMed ID: 19101227
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Disorders in high-density metabolism with insulin resistance and chronic kidney disease.
    Kaysen GA
    J Ren Nutr; 2007 Jan; 17(1):4-8. PubMed ID: 17198924
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Physical activity is associated with risk factors for chronic disease across adult women's life cycle.
    Woolf K; Reese CE; Mason MP; Beaird LC; Tudor-Locke C; Vaughan LA
    J Am Diet Assoc; 2008 Jun; 108(6):948-59. PubMed ID: 18502225
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lipid and lipoprotein metabolism in chronic kidney disease.
    Kaysen GA
    J Ren Nutr; 2009 Jan; 19(1):73-7. PubMed ID: 19121776
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The triglyceride/HDL-cholesterol ratio as a marker of cardiovascular risk in obese children; association with traditional and emergent risk factors.
    Quijada Z; Paoli M; Zerpa Y; Camacho N; Cichetti R; Villarroel V; Arata-Bellabarba G; Lanes R
    Pediatr Diabetes; 2008 Oct; 9(5):464-71. PubMed ID: 18507788
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Obesity and atherogenic dyslipidemia.
    Bamba V; Rader DJ
    Gastroenterology; 2007 May; 132(6):2181-90. PubMed ID: 17498511
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulation of high-density lipoprotein by inflammatory cytokines: establishing links between immune dysfunction and cardiovascular disease.
    Haas MJ; Mooradian AD
    Diabetes Metab Res Rev; 2010 Feb; 26(2):90-9. PubMed ID: 20047197
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High HDL-cholesterol in women with rheumatoid arthritis on low-dose glucocorticoid therapy.
    García-Gómez C; Nolla JM; Valverde J; Narváez J; Corbella E; Pintó X
    Eur J Clin Invest; 2008 Sep; 38(9):686-92. PubMed ID: 18837746
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Atherogenic dyslipidemia, metabolic syndrome and cardiovascular risk].
    Miccoli R; Ceraudo AM; Manfredi SG; Odoguardi L; Navalesi R
    Cardiologia; 1999 Oct; 44(10):885-99. PubMed ID: 10630048
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nutrition, body weight and deterioration of familial combined hyperlipidemia.
    Koprovicová J; Kollár J; Petrásová D
    Coll Antropol; 2006 Dec; 30(4):777-82. PubMed ID: 17243549
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Concerted actions of cholesteryl ester transfer protein and phospholipid transfer protein in type 2 diabetes: effects of apolipoproteins.
    Dallinga-Thie GM; Dullaart RP; van Tol A
    Curr Opin Lipidol; 2007 Jun; 18(3):251-7. PubMed ID: 17495597
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A 52-week, randomized, open-label, parallel-group comparison of the tolerability and effects of pitavastatin and atorvastatin on high-density lipoprotein cholesterol levels and glucose metabolism in Japanese patients with elevated levels of low-density lipoprotein cholesterol and glucose intolerance.
    Sasaki J; Ikeda Y; Kuribayashi T; Kajiwara K; Biro S; Yamamoto K; Ageta M; Kobori S; Saikawa T; Otonari T; Kono S
    Clin Ther; 2008 Jun; 30(6):1089-101. PubMed ID: 18640465
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Lipid metabolic disorders in obesity: their epidemiology, physiopathology and clinico-therapeutic implications].
    Campanini M; Lunati F; Zigrossi P; Monteverde A
    Ann Ital Med Int; 1997; 12(4):223-9. PubMed ID: 9773577
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of combination nicotinic acid and gemfibrozil treatment on intermediate density lipoprotein, and subclasses of low density lipoprotein and high density lipoprotein in patients with combined hyperlipidemia.
    Superko HR; Garrett BC; King SB; Momary KM; Chronos NA; Wood PD
    Am J Cardiol; 2009 Feb; 103(3):387-92. PubMed ID: 19166694
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.